Literature DB >> 18333254

Surgery for liver metastases from breast cancer.

Dominique Elias1, Daniela Di Pietroantonio.   

Abstract

Liver metastases develop in approximately half of women with metastatic breast cancer, and are typically associated with metastases at other sites, indicating advanced disease and poor prognosis. Whenever possible, hormonal therapy should be administered, until resistance develops. Several series in the literature have reported a poor effect of chemotherapy alone in patients with metastatic breast cancer, therefore liver surgery could be considered as an adjuvant treatment to systemic therapy in highly selected patients. This study looked at recent case series in the literature, and analysed prognostic factors and indications for surgery.

Entities:  

Year:  2006        PMID: 18333254      PMCID: PMC2131416          DOI: 10.1080/13651820500471871

Source DB:  PubMed          Journal:  HPB (Oxford)        ISSN: 1365-182X            Impact factor:   3.647


  17 in total

Review 1.  [Surgical treatment of non-colorectal and non-endocrine liver metastases].

Authors:  B Malassagne; D Goere; D Cherqui; P L Fagniez
Journal:  Gastroenterol Clin Biol       Date:  2000-12

2.  Liver metastases from breast cancer: long-term survival after curative resection.

Authors:  M Selzner; M A Morse; J J Vredenburgh; W C Meyers; P A Clavien
Journal:  Surgery       Date:  2000-04       Impact factor: 3.982

Review 3.  Combining new agents with anthracyclines in metastatic breast cancer: an overview of recent findings.

Authors:  M S Aapro
Journal:  Semin Oncol       Date:  1999-02       Impact factor: 4.929

4.  Partial hepatectomy for metastases from noncolorectal, nonneuroendocrine carcinoma.

Authors:  Jürgen Weitz; Leslie H Blumgart; Yuman Fong; William R Jarnagin; Michael D'Angelica; Lawrence E Harrison; Ronald P DeMatteo
Journal:  Ann Surg       Date:  2005-02       Impact factor: 12.969

5.  Liver resection for breast cancer metastases.

Authors:  J K Seifert; T F Weigel; U Gönner; T C Böttger; T Junginger
Journal:  Hepatogastroenterology       Date:  1999 Sep-Oct

6.  Hepatic resection for metastatic breast cancer: prognostic analysis of 34 patients.

Authors:  Yoshihiro Sakamoto; Junji Yamamoto; Masataka Yoshimoto; Fujio Kasumi; Tomoo Kosuge; Norihiro Kokudo; Masatoshi Makuuchi
Journal:  World J Surg       Date:  2005-04       Impact factor: 3.352

7.  The regional treatment of liver metastases from breast cancer.

Authors:  S Schneebaum; M J Walker; D Young; W B Farrar; J P Minton
Journal:  J Surg Oncol       Date:  1994-01       Impact factor: 3.454

Review 8.  An attempt to clarify indications for hepatectomy for liver metastases from breast cancer.

Authors:  Dominique Elias; Franck Maisonnette; Michel Druet-Cabanac; Jean Francois Ouellet; Jean Marc Guinebretiere; Marc Spielmann; Suzette Delaloge
Journal:  Am J Surg       Date:  2003-02       Impact factor: 2.565

9.  Liver metastases from breast cancer. Results of surgical resection.

Authors:  Massimo Carlini; Maria Teresa Lonardo; Fabio Carboni; Marija Petric; Carlo Vitucci; Roberto Santoro; Pasquale Lepiane; Giuseppe M Ettorre; Eugenio Santoro
Journal:  Hepatogastroenterology       Date:  2002 Nov-Dec

10.  Breast liver metastases--incidence, diagnosis and outcome.

Authors:  A L Hoe; G T Royle; I Taylor
Journal:  J R Soc Med       Date:  1991-12       Impact factor: 18.000

View more
  10 in total

Review 1.  Intensified neoadjuvant multimodal approach in synchronous liver metastases from gastric cancer: a single institutional experience.

Authors:  L Ceniceros; A Chopitea; F Pardo; F Rotellar; L Arbea; J J Sola; J C Subtil; B Sangro; A Benito; J L Hernández-Lizoain; J Rodríguez
Journal:  Clin Transl Oncol       Date:  2017-10-17       Impact factor: 3.405

2.  Peptidomimetic Src/pretubulin inhibitor KX-01 alone and in combination with paclitaxel suppresses growth, metastasis in human ER/PR/HER2-negative tumor xenografts.

Authors:  Muralidharan Anbalagan; Alaa Ali; Ryan K Jones; Carolyn G Marsden; Mei Sheng; Latonya Carrier; Yahao Bu; David Hangauer; Brian G Rowan
Journal:  Mol Cancer Ther       Date:  2012-07-10       Impact factor: 6.261

Review 3.  Thermal ablation therapies in patients with breast cancer liver metastases: a review.

Authors:  Thomas J Vogl; Parviz Farshid; Nagy N N Naguib; Stephan Zangos
Journal:  Eur Radiol       Date:  2012-10-13       Impact factor: 5.315

Review 4.  Liver resection in selected patients with metastatic breast cancer: a single-centre analysis and review of literature.

Authors:  Y Dittmar; A Altendorf-Hofmann; S Schüle; M Ardelt; O Dirsch; I B Runnebaum; U Settmacher
Journal:  J Cancer Res Clin Oncol       Date:  2013-05-04       Impact factor: 4.553

Review 5.  Liver metastases from non-gastrointestinal non-neuroendocrine tumours: review of the literature.

Authors:  Flavia Neri; Giorgio Ercolani; Paolo Di Gioia; Massimo Del Gaudio; Antonio Daniele Pinna
Journal:  Updates Surg       Date:  2015-08-08

6.  Specificity of the anti-glycolytic activity of 3-bromopyruvate confirmed by FDG uptake in a rat model of breast cancer.

Authors:  Manon Buijs; Josephina A Vossen; Jean-Francois H Geschwind; Takayoshi Ishimori; James M Engles; Obele Acha-Ngwodo; Richard L Wahl; Mustafa Vali
Journal:  Invest New Drugs       Date:  2008-06-14       Impact factor: 3.850

Review 7.  Renewed considerations on the utility (or the futility) of hepatic resections for breast cancer liver metastases.

Authors:  Gian Luca Grazi
Journal:  Hepatobiliary Surg Nutr       Date:  2021-01       Impact factor: 8.265

8.  High-intensity focused ultrasound provides palliation for liver metastasis causing gastric outlet obstruction: case report.

Authors:  Michele Rossi; Claudio Raspanti; Ernesto Mazza; Ilario Menchi; Angelo Raffaele De Gaudio; Riccardo Naspetti
Journal:  J Ther Ultrasound       Date:  2013-07-01

9.  A case report of the sustained and rapid response of bevacizumab in a TP53-positive breast cancer and liver metastatic patient through personalized medicine.

Authors:  Mohammad Reza Eskandarion; Zahra Tizmaghz; Bahram Andalib; Nasser Parsa; Seyed Amir Hossein Emami; Reza Shahsiah; Mohammad Ali Oghabian; Reza Shirkoohi
Journal:  Front Oncol       Date:  2022-09-02       Impact factor: 5.738

10.  Prognostic factors related to surgical outcome of liver metastases of breast cancer.

Authors:  Daniel V Kostov; Georgi L Kobakov; Daniel V Yankov
Journal:  J Breast Cancer       Date:  2013-06-28       Impact factor: 3.588

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.